J Dawn Abbott Associate Professor of Medicine

J. Dawn Abbott, M.D., is the Director of the Interventional Cardiology Fellowship Training Program at Brown and an interventional cardiologist at Rhode Island Hospital. Her clinical research focuses on percutaneous coronary intervention and peripheral arterial disease. She is a Co-Investigator on the NIH-Sponsored MINT Trial, a grant that is funding a pilot trial to evaluate the role of transfusion therapy in patients with symptomatic coronary artery disease. She is the Site-Principal Investigator at Rhode Island Hospital for several NIH funded studies (Dynamic Registry of Percutaneous Coronary Intervention, PACE-MI, BARI 2D) as well as multicenter investigator initiated and industry funded trials. She has examined the importance of several factors such as stent selection (drug-eluting versus bare metal), gender, and antiplatelet therapy on outcomes in percutaneous intervention. Current actively enrolling trials include the SAFE-PCI trial examining radial versus femoral access for coronary intervention in women, the RIVER-PCI trial assessing the use of the antianginal drug ranolazine in patients with incomplete revascularization, and the renalguard study examining prevention of contrast induced nephropathy by forced diuresis.

Brown Affiliations

selected